Physician

Adam Harrington Richman, MD

According to 2025 Medicare claims, Adam Richman, MD (NPI: 1417485293) practices radiation oncology in the Rochester, NY market, with the plurality of this provider's patient population coming from Monroe, NY. This provider's primary affiliated billing organization is ROCHESTER GENERAL HOSPITAL (NPI: 1356412712; TIN: 160743134) and primary practice location at 14621-3001. Richman is affiliated with the Rochester Regional Health ACO, Inc. (ACO ID: A3476), participating under the MSSP model.

Richman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 42 traditional Medicare patients, billed 547 HCPCS/CPT codes, and received $37,596 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 117 prescription claims across 46 beneficiaries totaling $8,961 in drug costs, led by Mometasone Furoate (Mometasone Furoate). Open Payments data shows 1 records totaling $24. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$19K$38K2022 Medicare payment: $13,083 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $33,959 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $37,596 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202224183$13,083
202343507$33,959
202442547$37,596

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.5K$9.0K2017 Drug cost: $2,640 (USD; Tot_Drug_Cst)2022 Drug cost: $428 (USD; Tot_Drug_Cst)2023 Drug cost: $4,628 (USD; Tot_Drug_Cst)2024 Drug cost: $8,961 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20172477$2,640
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20222227$428
202355112$4,628
202446117$8,961

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more1515$130
77263Complex radiation therapy planning1719$113
77334Design and construction of complex radiation treatment device1630$45
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1921$41
77300Calculation of radiation therapy dose1759$21

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Mometasone FuroateMometasone Furoate23758$608
Tamsulosin HclTamsulosin Hcl171,550$371

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$24Sumitomo Pharma America, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Harrington Richman, MD?

Tedicare shows public-source Medicare data for Adam Harrington Richman, MD (NPI 1417485293), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Harrington Richman, MD have ACO affiliation data?

Adam Harrington Richman, MD is shown with ACO affiliation data for Rochester Regional Health ACO, Inc. (MSSP, ACO ID A3476).

What billing organization is linked to Adam Harrington Richman, MD?

Adam Harrington Richman, MD is linked to ROCHESTER GENERAL HOSPITAL (billing NPI 1356412712) in the available physician profile data.

Does Adam Harrington Richman, MD have Open Payments data?

Adam Harrington Richman, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.